Truist Financial Corp Ionis Pharmaceuticals Inc Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 7,348 shares of IONS stock, worth $259,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,348

Previous 8,003 8.18%

Holding current value

$259,898

Previous $381,000 22.83%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.06 - $51.86 $26,239 - $33,968	-655 Reduced 8.18%	7,348 $294,000
Q2 2024 Aug 20, 2024	SELL	$36.45 - $47.7 $54,529 - $71,359	-1,496 Reduced 15.75%	8,003 $381,000
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $19,585 - $24,954	-466 Reduced 4.68%	9,499 $411,000
Q4 2023 Feb 02, 2024	BUY	$43.39 - $51.63 $432,381 - $514,492	9,965 New	9,965 $504,000
Q3 2022 Oct 26, 2022	SELL	$36.54 - $48.66 $582,593 - $775,835	-15,944 Reduced 71.29%	6,420 $284,000
Q2 2022 Jul 22, 2022	SELL	$31.71 - $43.0 $282,409 - $382,958	-8,906 Reduced 28.48%	22,364 $828,000
Q1 2022 Apr 22, 2022	BUY	$29.88 - $37.04 $9,950 - $12,334	333 Added 1.08%	31,270 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $1,024 - $1,404	-40 Reduced 0.13%	30,937 $941,000
Q3 2021 Nov 05, 2021	BUY	$33.54 - $40.55 $197,081 - $238,271	5,876 Added 23.41%	30,977 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $118,713 - $162,398	3,437 Added 15.87%	25,101 $1 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $442,444 - $663,822	10,408 Added 92.47%	21,664 $974,000
Q4 2020 Nov 19, 2021	SELL	$45.3 - $60.27 $438,730 - $583,714	-9,685 Reduced 46.25%	11,256 $636,000
Q4 2020 Feb 18, 2021	BUY	$45.3 - $60.27 $429,353 - $571,239	9,478 Added 82.68%	20,941 $1.18 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $18,600 - $24,676	-392 Reduced 3.31%	11,463 $545,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $8,573 - $11,172	183 Added 1.57%	11,855 $698,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $66,934 - $102,010	-1,609 Reduced 12.12%	11,672 $551,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $715,181 - $866,850	13,281 New	13,281 $802,000

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Ionis Pharmaceuticals Inc Transaction History